BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang D, Zhou Z, Yang R, Zhang S, Zhang B, Tan Y, Chen L, Li T, Tu J. Tristetraprolin, a Potential Safeguard Against Carcinoma: Role in the Tumor Microenvironment. Front Oncol 2021;11:632189. [PMID: 34026612 DOI: 10.3389/fonc.2021.632189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Jeon DY, Jeong SY, Lee JW, Kim J, Kim JH, Chu HS, Jeong WJ, Lee BJ, Ahn B, Kim J, Choi SH, Park JW. FOXO1 Is a Key Mediator of Glucocorticoid-Induced Expression of Tristetraprolin in MDA-MB-231 Breast Cancer Cells. Int J Mol Sci 2022;23. [PMID: 36430156 DOI: 10.3390/ijms232213673] [Reference Citation Analysis]
2 Serhii K, Anastasiia H, Oksana M, Liubov S, Nataliia V, Sergii L, Kyrylo L, Iryna I, Rostyslav S, Alla R. Tristetraproline in breast cancer: treat or trick?. [DOI: 10.1101/2022.05.23.493030] [Reference Citation Analysis]